Selling pressure pushes Colgate-Palmolive stock lower in today's trading

Traders Union
All News
Financial News
Colgate-palmolive slides 3.23% today

Highlights

Colgate-Palmolive renewed its over 50-year partnership with The University of Manchester, investing £2 million for advanced oral health research initiatives.
The new funding will support the Dental Health Unit's research and public health policy projects, reflecting the strategic focus despite current share price pressures.
Shares are under sustained selling pressure, trading below key short- and medium-term averages, with upcoming five-day range expected between $83.94 and $87.64; rebound odds stand at 75% if resistance at $88.08 breaks.

Strategic funding boost as price lags under broader selling

Colgate-Palmolive renewed and extended its partnership with The University of Manchester by pledging £2 million in support, continuing their over 50-year collaboration for advancing global oral health research and behavioral change initiatives. The Dental Health Unit will benefit from this funding, enabling ongoing research and public health policy development. University representatives noted the strategic importance of these projects, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, sees Colgate-Palmolive under clear selling pressure. The stock trading below short-term moving averages and a daily loss of 3.23% signal potential weakness. Technical signals remain mixed, with bearish or neutral momentum outweighing positive cues. The news of renewed partnership with The University of Manchester failed to reverse sentiment or spark buying interest. "The persistent dominance of sellers and inability for positive news to drive recovery highlight downside risk — staying defensive is prudent here."

Viktoras Karapetjanc, expert at Traders Union, highlights Colgate-Palmolive's positive engagement with global health initiatives. He believes this renewed collaboration strengthens the company's long-term strategic outlook and supports its reputation. Despite recent price weakness, the baseline scenario signals sideways action, with core weekly indicators favoring a rebound. Karapetjanc sees opportunity for further growth if resistance at $88.08 breaks. "The bullish structure remains intact, and long-term investors should see these levels as a constructive entry point for future gains."

Parshwa Turakhiya, analyst, notes notable short-term volatility and a sharp intraday gap for Colgate-Palmolive. Momentum oscillators are flashing oversold conditions and suggest near-term sentiment may be stretched to the downside. Turakhiya sees the stock caught between weak trend strength and the potential for a technical rebound. Short-term setups favor watching for a quick reversal if $83.94 holds as support. "With sellers in control but the BBP and Stochastic RSI at extremes, nimble traders should prepare for a potential bounce or fast sentiment shift."

Oversold momentum divergence as sellers dominate intraday action

Momentum signals are mixed: the MACD on the daily chart remains strongly positive, but the Average Directional Index (ADX) shows weak trend strength. The Relative Strength Index (RSI) and Commodity Channel Index (CCI) both lean bearish or neutral, while the Stochastic RSI and Bull/Bear Power (BBP) signal the stock is in oversold territory and sellers dominate intraday momentum. The Awesome Oscillator is neutral and does not reinforce the current trend. The stock has fallen $2.85 or 3.23% today, opening with a downside gap of roughly $1.51 and trading near the session low, with intraday volatility at 1.74%. The tone is under sustained selling pressure after the open. This downside action is consistent with dominance of sellers, although positive daily MACD reflects a divergence between short-term momentum and broader daily performance.

Earlier, analysts noted that sustained selling pressure was weighing on major consumer stocks and keeping key technical indicators in bearish territory. Recent price action in Colgate-Palmolive adds a new dimension, as the stock's steep intraday decline and oversold signals set the stage for potential volatility around support at $83.94 in the days ahead.

Source of Data: CL Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.